Terms and Data
Intraday Chart Close
Strike48.5 Moneyness48.7% OTM
Effective Gearing* 9.5 Delta* 7%
Implied Volatility67.6% Vega6.9%
Entitlement Ratio10 Outstanding Quantity
(M Shares) / %22.0/ 31.5%
Theta-6.66% Premium (%)49.4
Maturity
(Y-M-D)2026-01-23
Break-Even (HKD)48.74
Listing 2025-08-22
Today 2025-12-06
Last Trading 2026-01-19
Maturity 2026-01-23
Last Trade Date (Y-M-DD)2026-01-19 Board Lot (Shares)5,000
Approximate Change for 1 Tick
Price Change of warrants(Sensitivity)*0.1
 
Listing 2025-08-22
Today 2025-12-06
Last Trading 2026-01-19
Maturity 2026-01-23
*Effective Gearing and Delta are derived from J.P. Morgan’s proprietary pricing model. These parameters reflect the relationship between the price of the underlying asset and the theoretical price changes of the Warrants. Investors should note that these figures are for reference only and may fluctuate with changes in the underlying asset price and the remaining time to maturity of the Warrants. In addition to the performance of the underlying asset, the Warrants price may also be affected by other market factors. For details, please refer to our educational articles and the listing documents.
Related Document
Listing Document Download Additional DocumentDownload Announcement-
Underlying
2269 WUXI BIO(Delayed*)
32.62
Change (%)
-0.320 (-1.0%)
  • High 33.22
  • Low 32.38
  • Turnover 1.2 (B)
Warrant Money Flow of Underlying More
Last Day
0.15(M)
-0.00(M)
5 Days
0.22(M)
0.01(M)
  • Money In-Flow
  • Money Out-Flow
Last Updated Time : 2025-12-05 16:35   |   (Delayed*) - Minimum 15 mins delayed
  • 2025-10-13 【焦點股】藥明系顯著受壓 藥明生物及藥明康德半日跌幅介乎8-9% 藥明購 19577 藥康購 19881
  • 2025-07-24 【焦點股份】藥明生物發盈喜 預期上半年淨利潤同比成長約56% 藥明購17665/沽 18043
  • 2025-06-17 【醫藥行業】內地擬縮短核心創新藥品種的臨床試驗審評審批周期 以支持新藥研發 石藥購 17388 藥明購14010